Charlie's Law Benefits Regenerative Medicine and Stem Cell Research in Texas

Director of Regenerative Medicine Research Doris Taylor, Ph.D., joined Texas lawmakers on a panel last week to discuss “Charlie’s Law,” which was passed unanimously by the state legislature during the 85th Legislative Session this summer. Charlie’s Law, the first of its kind in the United States, allows patients with chronic or terminal illnesses to access experimental stem cell interventions in Texas.